Graft material and results of platelet inhibitor trials in peripheral arterial reconstructions: Reappraisal of results from a meta-analysis

British Journal of Clinical Pharmacology

Volumn 49, Issue 5, 2000, Pages 479-483

  Watson, Hugh R ^a,b,c   Skene, Allan M ^a   Belcher, Glyn ^b  

^a Scark European Clinical R and D ^*  (France)

^b Nottingham And3takeda European RandD Centre   (United Kingdom)

^c Searle European Clinical R and D   (France)

Author keywords

Graft material; Meta analysis; Peripheral bypass; Platelet inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; SULFINPYRAZONE;

ARTERY; ARTERY GRAFT; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAFT PATENCY; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; SMOKING;

ARTERIES; BLOOD VESSEL PROSTHESIS IMPLANTATION; HUMANS; META-ANALYSIS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS;

EID: 0034012662     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00178.x     Document Type: Article

References (21)

1. Rutherford RI3, Jones DN, Bergentz S-E, et al. Factors affecting the patency of infrainguinal bypass. J Vase Surg 1988; 8: 236-246.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy -II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994; 308: 159-168.
3. Zekert F. Klinische Anwendung von Aggregationshemniem bei arterieller Verschlusskrankheit. In Tlirotubosen, Einbauen und Aggrcgationsheinmer in der Chirurgie, ed. Zekert F. Stuttgart: Schattauer, 1975: 68-72.
4. Ehresmann U, Alemany J, Loew D. Prophylaxe von Rezidiwerschlüssen nach Revaskularisationseingriffen mit Acetylssalicylsäure. Med Weh 1977; 28: 1157-1162.
5. Harjola P-T, Meurala H, Frick HH. Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. J Cardiovasc Surg (Torino) 1981; 22: 141-144.
6. Green RM, Roedersheimer LR, DeWeese JA. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 1982; 92: 1016-1026.
7. Comberg HU, Janssen EJ, Diehm C, et al. Sulphinpyrazone versus Placebo nach operativer Rekonstruktion der Oberschenkeletage bei arterieller Verschlusskrankheit. Vasa 1983; 12: 172-178.
8. Goldman M, McCollum C. A prospective randomised study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts. Vase Surg 1984; 18: 217-221.
9. Kohler TR, Kaufman JL, Kacoyanis G, et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 1984; 96: 462-466.
10. Donaldson DR, Salter MCP, Kester RC, et al. The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. Vase Surg 1985; 19: 224-230.
11. Satiani D. A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts. Angiol 1985; 36: 608-616.
12. Clyne CAC, Archer TJ, Atuhaire LK, Chant ADD, Webster JHH. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts. BrJ Snrg 1987; 74: 246-248.
13. McCollum CN, Alexander CE, Kenchington G, Franks PJ, Greenhalgh RM. Antiplatelet drugs in femoro-popliteal vein bypass: a multicentre trial. J Vase Surg 1991; 13: 150-162.
14. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD. Experience with in situ saphenous vein bypasses during 1981-89: Determinant factors of long-term patency J Vase Surg 1991; 13: 137-149
15. Sayers RD, Thompson MM, Dunlop P, London NJM, Bell PRF. The fate of infra-inguinal PTFE grafts and an analysis of factors affecting outcome. EurJ Vase Surg 1994; 8: 607-610.
16. Bergqvist D. Pharmacologie prevention of graft occlusion. Ada Chir Scand 1985; Suppl 529: 107-114.
17. European Working Group on Critical Limb Ischaemia. Second European Consensus Document on Chronic Critical Limb Ischaemia. Circulation 1991; 84(Suppl): 4.
18. Antiplatelet Trialists" Collaboration. Collaborative overview of randomised trials of antiplatelet therapy -I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br MedJ 1994; 308: 81-106.
19. BecqueminJ-P. Effect of ticlopidine on the long-term patency of saphenous vein bypass grafts in the legs. N EnglJ Meet 1997; 337: 1726-1731.
20. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. Br MedJ 1994; 309: 1351-1355.
21. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stats Med 1998; 17: 841-856.